Insulin degludec and liraglutide and Mogamulizumab-kpkc Intravenous
Determining the interaction of Insulin degludec and liraglutide and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin Degludec and Liraglutide
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide-Molindone
- Insulin degludec and liraglutide-Mometasone (Oral Inhalation)
- Insulin degludec and liraglutide-Mometasone and Formoterol
- Insulin degludec and liraglutide-Mometasone and formoterol Inhalation
- Insulin degludec and liraglutide-Mometasone Cream
- Insulin degludec and liraglutide-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Insulin degludec and liraglutide Subcutaneous
- Mogamulizumab-kpkc Intravenous-Insulin degludec Subcutaneous
- Mogamulizumab-kpkc Intravenous-Insulin detemir
- Mogamulizumab-kpkc Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Mogamulizumab-kpkc Intravenous-Insulin Detemir (Vials)
- Mogamulizumab-kpkc Intravenous-Insulin detemir Subcutaneous